Nishikawa T, Scatton B
Brain Res. 1985 Apr 1;331(1):91-103. doi: 10.1016/0006-8993(85)90718-8.
Acute injection of the gamma-aminobutyric acid (GABA) mimetics progabide, aminooxyacetic acid, gamma-acetylenic GABA and dipropylacetamide reduced 5-hydroxytryptophan (5-HTP) accumulation in serotonergic nerve terminal regions (prefrontal cortex, olfactory tubercle, septum, striatum, hypothalamus, hippocampus, substantia nigra, cerebellum and spinal cord) as well as in corresponding cell body areas (raphé dorsalis, medianus, pontis and magnus). This effect was antagonized by bicuculline. The inhibition of serotonin (5-HT) synthesis induced by a single progabide administration was accentuated on repeated treatment in the striatum, prefrontal cortex and cerebellum but was similar to that seen after acute treatment in the other areas. Local infusion of high concentrations of GABA or GABA mimetics into the striatum, septum or substantia nigra failed to modify 5-HTP accumulation in these areas. Cerebral hemitransection antagonized the ability of progabide (1200 mg/kg i.p.) to diminish 5-HTP accumulation in the striatum, hippocampus and prefrontal cortex. Intra-raphé dorsalis infusion of muscimol (0.1-100 ng) or GABA (1-100 micrograms) decreased 5-HT synthesis in the corresponding projection areas (e.g. striatum, substantia nigra, cortex) but not in the hippocampus or cerebellum. Conversely, intra-raphé medianus infusion of these drugs diminished 5-HTP accumulation in the corresponding projection areas (e.g. hippocampus, septum, cortex) but not in the striatum or cerebellum. Intra-raphé dorsalis or medianus injection of GABA antagonists (bicuculline, picrotoxinin, RU-5135) was without effect on cerebral 5-HT synthesis but antagonized the diminution of the amine synthesis observed in corresponding projection areas after intra-raphé dorsalis or medianus infusion of muscimol or GABA. These results suggest that GABA exerts an inhibitory (non-tonic) control over central serotonergic neurons which is mediated via GABA receptors located in the raphé nuclei.
急性注射γ-氨基丁酸(GABA)模拟物丙戊茶碱、氨氧基乙酸、γ-乙炔基GABA和二丙基乙酰胺可减少5-羟色氨酸(5-HTP)在5-羟色胺能神经终末区域(前额叶皮质、嗅结节、隔区、纹状体、下丘脑、海马、黑质、小脑和脊髓)以及相应细胞体区域(背侧中缝核、中缝正中核、脑桥中缝核和中缝大核)的蓄积。这种作用可被荷包牡丹碱拮抗。单次给予丙戊茶碱所诱导的5-羟色胺(5-HT)合成抑制在纹状体、前额叶皮质和小脑中经重复给药后会增强,但在其他区域与急性给药后所见相似。向纹状体、隔区或黑质局部注入高浓度的GABA或GABA模拟物未能改变这些区域中5-HTP的蓄积。大脑半横断可拮抗丙戊茶碱(1200mg/kg腹腔注射)减少纹状体、海马和前额叶皮质中5-HTP蓄积的能力。向背侧中缝核内注入蝇蕈醇(0.1 - 100ng)或GABA(1 - 100μg)可降低相应投射区域(如纹状体、黑质、皮质)中的5-HT合成,但在海马或小脑中则不然。相反,向中缝正中核内注入这些药物可减少相应投射区域(如海马、隔区、皮质)中的5-HTP蓄积,但在纹状体或小脑中则不然。向背侧中缝核或中缝正中核内注射GABA拮抗剂(荷包牡丹碱、印防己毒素、RU - 5135)对脑内5-HT合成无影响,但可拮抗在向背侧中缝核或中缝正中核内注入蝇蕈醇或GABA后在相应投射区域中所观察到的胺合成减少。这些结果表明,GABA对中枢5-羟色胺能神经元发挥抑制性(非紧张性)控制,这是通过位于中缝核中的GABA受体介导的。